Vytorin Cancer Link Not Seen by FDA
Federal regulators indicate that it is unlikely that the cholesterol drug Vytorin causes cancer, despite a clinical study in 2008 which raised potential Vytorin cancer concerns.
Federal regulators indicate that it is unlikely that the cholesterol drug Vytorin causes cancer, despite a clinical study in 2008 which raised potential Vytorin cancer concerns.
Data from a new study on cholesterol-fighting drugs suggest that side effects of statins, a class of medications that includes popular medications like Crestor, Lipitor and Zocor, could increase the…
Despite reports that emerged last year linking side effects of Vytorin and Zetia to an increased incidence of cancer, a new study suggests that the cholesterol drugs are not associated…
A new study has found that cholesterol drug Vytorin provides no benefit in reducing the risk of major heart-valve problems, raising questions about why the drug is still on the…